A new study is being launched in England today to determine the best interval between doses for vaccinating pregnant women against COVID-19. Research indicates pregnant women are more at risk of serious illness from COVID-19. The Pfizer/BioNTech and Moderna vaccines have been recommended for use in pregnancy, however, information on the response to the vaccine during pregnancy is lacking. The trial will study vaccine intervals of 4 to 6 weeks and 8 to 12 weeks.